Observational studyBMC anesthesiology2026
Association between supraphysiological estradiol levels and propofol injection pain: a prospective observational study.
Observational study in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06929416 (Relationship Between Serum Estrogen Concentration and Propofol Injection Pain), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Relationship Between Serum Estrogen Concentration and Propofol Injection Pain: A Prospective and Observational Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPain on propofol injection (POPI) remains a distressing problem despite preventive strategies. Estradiol, a major estrogen, has been implicated in nociceptive and inflammatory pathways. This study aimed to determine whether supraphysiological estradiol levelsare associated with the incidence of POPI and with pain severity among patients experiencing pain.
methodsNinety female patients (ASA I–II, 18–45 years) undergoing elective surgery under general anesthesia were enrolled in this prospective observational study. Patients were divided into two groups based on preoperative estradiol concentration: supraphysiological (IVF, > 350 pg/mL) and normal (non-IVF, 15–350 pg/mL). Propofol (2–2.5 mg/kg) was injected without lidocaine pretreatment. POPI severity was assessed using a four-point behavioral scale (0–3). Correlation analyses and receiver operating characteristic (ROC) analyses were performed to evaluate the association and discriminative performance of estradiol concentration with propofol injection pain.
resultsPOPI occurred more frequently in the IVF group (95.6%) than in the non-IVF group (68.9%, p = 0.001). Median estradiol levels were significantly higher in patients with pain (1096.5 vs. 88 pg/mL, p < 0.001). Among patients experiencing pain, estradiol levels showed a modest positive correlation with pain severity (r = 0.34, p = 0.003). ROC analysis yielded an area under the curve (AUC) of 0.847 (95% CI: 0.755–0.939) with an optimal cut-off of 122 pg/mL (sensitivity 87.8%, specificity 75%). This cut-off should be considered exploratory within this single-center cohort.
conclusionsSupraphysiological estradiol levels were associated with a higher incidence of POPI. In addition, estradiol concentration showed a modest correlation with pain severity among patients who experienced pain. These findings demonstrate an association between estradiol concentration and propofol injection pain within the studied population.
trial registrationNCT06929416, date: April 8, 2025, first patient registration date: May 2, 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.